Rubicon Research Pvt Ltd
General
Total Cases2
Active Cases1
Patents12
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 07/18/24 | SO ORDERED, re 10 Motion for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs filed by Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Pharmaceuticals, Inc. Ordered by Judge Jennifer L. Hall on 7/18/2024. (ceg) (Entered: 07/18/2024) | |
| 07/17/24 | SUMMONS Returned Executed by Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Centre Hospitalier Universitaire de Bordeaux, Universite de Bordeaux.Rubicon Research Private Limited served on 7/15/2024, answer due 8/5/2024. (Jones, Keith) (Entered: 07/17/2024) | |
| 07/17/24 | Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) (Entered: 07/17/2024) | |
| 07/15/24 | Pro Hac Vice Fee - Credit Card Payment received for Philip L. Hirschhorn and Erin M. Dunston. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs )( Payment of $ 100, receipt number ADEDC-4450747).(Jones, Keith) (Entered: 07/15/2024) | |
| 07/15/24 | MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn and Erin M. Dunston of Panitch Schwarze Belisario & Nadel LLP to represent Plaintiffs - filed by Centre Hospitalier Universitaire de Bordeaux, Pierre Fabre Medicament SAS, Pierre Fabre Pharmaceuticals, Inc., Universit de Bordeaux. (Attachments: # 1 Certification (Philip L. Hirschhorn), # 2 Certification (Erin M. Dunston))(Jones, Keith) (Entered: 07/15/2024) | |
| 07/12/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent New Ways to Care Pharma for Pierre Fabre Pharmaceuticals, Inc. filed by Pierre Fabre Pharmaceuticals, Inc.. (Simmons, John) (Entered: 07/12/2024) | |
| 07/12/24 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 07/12/2024) | |
| 07/12/24 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Universit de Bordeaux. (Simmons, John) (Entered: 07/12/2024) | |
| 07/12/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pierre Fabre SA for Pierre Fabre Medicament SAS filed by Pierre Fabre Medicament SAS. (Simmons, John) (Entered: 07/12/2024) | |
| 07/12/24 | Summonses Issued (please complete the top portion of the form and print out for use/service). (oam) (Entered: 07/12/2024) |